RONALD CABLE: Open Payments
NPI 1467430900 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 9 payments from 6 companies in 2025. Trend: 2023 $115 · 2024 $199 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $15 |
Products named: NUPLAZID, REXULTI, INGREZZA, ZENPEP, ARISTADA.
Industry payments across OK — which companies pay providers there.
